BioSpace News Archive

Biotech Beach

Balt USA, LLC Announces CE Mark Obtained for Titan™ Aspiration Catheter

Balt USA, LLC announces today it has obtained CE mark for the Titan aspiration catheter. T

May 13, 2019
·
2 min read
Business

Advaxis Announces Appointment of Dr. Robert Petit to Chair of Scientific Advisory Board and Departure as Chief Scientific Officer

Advaxis, Inc. (NASDAQ:ADXS) (the “Company”), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that Robert Petit, Ph.D. will be leaving his position as Chief Scientific Officer at the end of the month.

May 13, 2019
·
5 min read
Policy

“Surprise Billing” Ban Protects Insurers, Not Patients, States Association of American Physicians and Surgeons (AAPS)

In a letter to President Trump, the Association of American Physicians and Surgeons writes that reports on “surprise billing” make an effective emotional appeal, but legislation is actually being pushed by insurers to protect themselves against having to pay a fair market price for services patients need.

May 13, 2019
·
2 min read
Deals

Milestone Pharmaceuticals Announces Closing of Initial Public Offering

Milestone Pharmaceuticals Inc. announced the closing of its previously announced initial public offering of 5,500,000 of its common shares at a public offering price of $15.00 per share.

May 13, 2019
·
3 min read
Deals

Ra Medical Systems Reports First Quarter 2019 Financial Results

Ra Medical Systems, Inc. reports financial results for the three months ended March 31, 2019 and provides a business update.

May 13, 2019
·
10 min read
Pharm Country

Quest Diagnostics To Speak At The UBS Global Healthcare Conference

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York.

May 13, 2019
·
1 min read
FDA

FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy - May 13, 2019

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved EYLEA® Injection to treat all stages of diabetic retinopathy, and thereby reduce the risk of blindness.

May 13, 2019
·
13 min read
Business

UnitedHealthcare and Optum Take Action to Support People Affected by Flooding in Mississippi

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group, are taking action to help people affected by flooding across parts of Mississippi.

May 13, 2019
·
2 min read
Genetown

Ed Evarts of 3D Leadership Group Speaks at MAGI’s Clinical Research Conference

Ed Evarts, leadership development coach, management consulting for 3D Leadership Group (http://3dleadershipgroup.com), a Boston-based leadership development firm, recently presented at MAGI’s Clinical Research Conference – 2019 East, which was held May 5-8 at the Sheraton Boston Hotel in Boston

May 13, 2019
·
2 min read
BioCapital

Physicians, Patients Overwhelmingly Support FDA Distinct Biologic Naming Plan, Suffixes for New Products

US physicians and patient advocacy organizations expressed their overwhelming support for the FDA’s suffix-based naming system for biologic medicines and biosimilars, according to comments electronically submitted last week to the agency.

May 13, 2019
·
3 min read